BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 7622118)

  • 1. Ovarian strumal carcinoid with markedly high serum levels of tumor markers.
    Takemori M; Nishimura R; Sugimura K; Obayashi C; Yasuda D
    Gynecol Oncol; 1995 Aug; 58(2):266-9. PubMed ID: 7622118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexistence of struma ovarii with marked ascites and elevated CA-125 levels: case report and literature review.
    Mui MP; Tam KF; Tam FK; Ngan HY
    Arch Gynecol Obstet; 2009 May; 279(5):753-7. PubMed ID: 18807056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudo-Meigs syndrome and elevated CA125 associated with struma ovarii.
    Loizzi V; Cormio G; Resta L; Fattizzi N; Vicino M; Selvaggi L
    Gynecol Oncol; 2005 Apr; 97(1):282-4. PubMed ID: 15790478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
    Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
    Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors?
    Ayhan A; Guven S; Guven ES; Kucukali T
    Acta Obstet Gynecol Scand; 2007; 86(4):484-90. PubMed ID: 17486473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strumal carcinoid ovary with mucinous cystadenoma presenting as a large abdominal mass and increased tumour marker level.
    Bohara S; Agarwal S; Khuraijam B; Khurana N; Arora R
    J Obstet Gynaecol; 2013 Aug; 33(6):637-9. PubMed ID: 23919875
    [No Abstract]   [Full Text] [Related]  

  • 7. Ovarian strumal carcinoid--report of a case that matastasized.
    Khadilkar UN; Pai RR; Lahiri R; Kumar P
    Indian J Pathol Microbiol; 2000 Oct; 43(4):459-61. PubMed ID: 11344613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical value of serum CA19-9, CA125 and CP2 in mucinous ovarian tumor: a retrospective study of 273 patients].
    Dong L; Cui H; Li XP; Sun LF; Chang XH; Liang XD; Zhu HL
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):5-8. PubMed ID: 18366923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strumal carcinoid of the ovary. A case report.
    Takubo K; Yasui H; Toi K
    Acta Pathol Jpn; 1986 May; 36(5):765-71. PubMed ID: 3739710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Strumal carcinoid tumor of the ovary--histologic and electron microscopy characteristics of the tumor].
    Sarcević B; Separović V; Sćukanec-Spoljar M; Pejsa V
    Lijec Vjesn; 1990; 112(11-12):381-3. PubMed ID: 2097471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bilateral strumal ovarian carcinoid].
    Zahradka W; Schulz G
    Zentralbl Gynakol; 1990; 112(3):171-4. PubMed ID: 2336891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathologic aspects in a case of strumal carcinoid (struma ovarii and carcinoid).
    Nicolescu PG; Taşcă C; Sajin M
    Rom J Morphol Embryol; 1990; 36(2):125-7. PubMed ID: 2149420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of serum alpha-beta A immunoreactive inhibin and tumor-associated antigens CA125 and CEA in ovarian cancer.
    Phocas I; Sarandakou A; Sikiotis K; Rizos D; Kalambokis D; Zourlas PA
    Anticancer Res; 1996; 16(6B):3827-31. PubMed ID: 9042265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of CA125, CA19-9, CEA, CA72-4, and TPA in borderline ovarian tumor.
    Tamakoshi K; Kikkawa F; Shibata K; Tomoda K; Obata NH; Wakahara F; Tokuhashi Y; Ishikawa H; Kawai M; Tomoda Y
    Gynecol Oncol; 1996 Jul; 62(1):67-72. PubMed ID: 8690294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of malignant strumal carcinoid.
    Armes JE; Ostör AG
    Gynecol Oncol; 1993 Dec; 51(3):419-23. PubMed ID: 8112657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian strumal carcinoid in association with multiple endocrine neoplasia, type IIA.
    Tamsen A; Mazur MT
    Arch Pathol Lab Med; 1992 Feb; 116(2):200-3. PubMed ID: 1346363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
    Lai IR; Lee WJ; Huang MT; Lin HH
    Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Typical thyroid-type carcinoma arising in struma ovarii: a report of 4 cases and review of the literature.
    Roth LM; Miller AW; Talerman A
    Int J Gynecol Pathol; 2008 Oct; 27(4):496-506. PubMed ID: 18753973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strumal carcinoid tumor of the ovary: A rare case report.
    Chai W; Zhang W; Zhou L; Sun X; Jia G
    Medicine (Baltimore); 2019 Nov; 98(48):e18009. PubMed ID: 31770214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Struma ovarii and strumal carcinoid].
    Vasilev N; Mikhaĭlov I; Ganchev S; Makaveeva V; Vylcheva V
    Arkh Patol; 1984; 46(8):29-34. PubMed ID: 6149739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.